Diabetes Type 2 clinical trials at UC Irvine
2 research studies open to eligible people
Showing trials for
Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
open to eligible people ages 18-99
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Orange, California and other locations
HOPE Intervention for Fitness
open to eligible people ages 18 years and up
We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).
Irvine, California
Our lead scientists for Diabetes Type 2 research studies include Sean D Young.
Last updated: